Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

AMPH Relative to the S&P 500

AMPH Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Amphastar Pharmaceuticals, Inc. (NASD:AMPH) seasonal charts above shows that a Buy Date of April 18 and a Sell Date of July 26 has resulted in a geometric average return of 7.65% above the benchmark rate of the S&P 500 Total Return Index over the past 10 years. This seasonal timeframe has shown positive results compared to the benchmark in 8 of those periods. This is a very good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 10 years by an average of 8.44% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses?on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company’s finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

To download AMPH seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: AMPH